CD8A and neoplasm: However, G47Δ-mIL12 treatment led to significant trafficking of DCs in the spleens of treated mice versus PBS control group (Figure 4A), indicating that DCs primed in the tumor microenvironment following virus treatment likely trafficked to lymphoid organs for antigen presentation to immune cells such as CD8+ T cells (Figure 3C).